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Abstract Human neutrophil ipocalin (HNL) cDNA was ampli- 
fied by PCR technology in combination with deoxyinosine con- 
taining oligonucleotides for cloning, sequencing and production 
of the recombinant protein in E. coll. The primers were targeted 
to the corresponding DNA backtranslate of the mature protein 
resulting in a PCR amplified 534 bp cDNA from different reverse 
transcripts of ovarian cancer cell line and bone marrow cell 
mRNAs. Sequence analysis revealed that two different cDNAs 
from ovarian cancer and bone marrow cells could be obtained. 
Cloning and expression of HNL cDNAs were performed in E. coil 
strain HMS 174 [DE3] using the pET system yielding in two 
recombinant proteins with a molecular weight of 21 kDa which 
is consistent with an 178 amino acid residues containing sequence 
of the mature HNL protein. N-terminal amino acid sequence 
analysis of the expression products showed an identical polypep- 
tide sequence missing the E. coli processed starting methionine. 
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cDNA of the HNL  from the reverse transcripts of ovarian 
cancer cell line and bone marrow cell mRNA.  The obtained two 
different cDNAs could be cloned in E. coli and the rHNL could 
be expressed as a 21 kDa protein. 
2. Materials and methods 
Human bone marrow cells were a gift from Dr. F. Lindemann 
(Krankenanstalten Bethel, Bielefeld, Germany), human ovarian cancer 
cell lines OC 1, OC 2, OC 6 and OVCAR 3 were from Dr. O. Wilhelm 
(Frauenklinik der TU Miinchen, Klinikum r. d. Isar, Germany), E. coli 
strain HMS 174 [DE3] and plasmid vector pET 1 l a were from Novagen 
(Madison, USA), restriction enzymes were from Biolabs (Schwalbach, 
Germany). 
2.1. RNA preparation and reverse transcription 
Total RNA from 1 × l0  7 bone marrow cells and the ovarian cancer 
cell lines was prepared by the guanidinium isothiocyanate extraction 
procedure followed by ultracentrifugation through a cesium chloride 
gradient according to Chirgwin et al. [10]. First strand cDNA synthesis 
from 5/lg of total RNA was performed with Superscript (Lifetechnol- 
ogies, Inc.) by the manufacturer's protocol. 
I. Introduction 
HNL was first identified by Triebel et al. [1] as a 25 kDa 
gelatinase-associated glycosylated component of the 125 kDa 
gelatinase from human PMN leukocytes. Furthermore, the 
protein was localized in monomeric and dimeric forms in the 
specific granules of human neutrophils [2]. HNL  belongs to the 
lipocalin family. It has strong homologies with the rat ~2 mi- 
croglobulin-related protein [3] and the mouse oncogene protein 
24p3 [4]. Most lipocalins are carriers of small hydrophobic 
substances through the hydrophilic medium of the body [5]. 
HNL  has been shown to bind chemoattractants of the type of 
N-formyl peptides [6]. But its physiological role is still not clear. 
Although the amino acid sequence similarity among the mem- 
bers of the lipocalin family is low, there are three conserved 
regions containing the invariant residue tryptophan in one 
motif  [7]. Cristallographic studies of several ipocalins revealed 
that they exhibit also a high similarity in the folding pattern 
with an eight-stranded antiparallel t -barrel  fold into an orthog- 
onal calyx [8]. Chan et al. [9] have shown that lipocalin genes 
are part of conserved syntenies at HSA9q. 
Here we report on both the PCR amplification using oligonu- 
cleotides containing deoxyinosine and on the sequencing of the 
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2.2. Oligonucleotide synthesis 
Oligonucleotides were synthesized by Genosys Biotechnologies, Inc. 
according to the N-terminal and C-terminal amino acid sequences of 
the mature HNL protein. Deoxyinosine was introduced at the ambigu- 
ous codon positions in cases where more than two alternate deoxynu- 
cleotides would have been possible leading to following HNL-primers: 
5'-CAGGACTCIACITCIGACCTIATCCCIGCCCC-Y and 5'-CCG- 
TCIATGCAT TGATCIATIGGIACIGGGAA-3'. 
2.3. PCR amplification and cloning of HNL 
50 ng of first strand cDNA were used as template to amplify the HNL 
gene by PCR technology. Each reaction consisted of 100 pmol of 
primers, 0,2 mM dNTP, 1,5 mM MgCI 2 and 1 U of Taq DNA polym- 
erase (Lifetechnologies, Inc.) in 50/.tl of reaction buffer recommended 
by the manufacturer. Two combined amplification cycles with 40 s at 
95°C, 45 s 40°C, 90 s 72°C (5 cycles), 40 s 95°C, 60 s 50°C, 40 s+l 
s/cycle 72°C (33 cycles) were carried out on a MiniCycler (MJ Re- 
search, Inc.). 
2.4. Cloning and sequencing of the PCR amplification products 
PCR fragments were electrophoresed in agarose gels and purified by 
phenol extractions and ethanol precipitation before ligating the PCR 
product into the TA cloning vector pCR II (Invitrogen Corp., San 
Diego, USA) using the manifacturer's protocol. This system takes ad- 
vantage of the nontemplate d pendent activity of thermostable polym- 
erases used in PCR that add single deoxyadenosines to the 3'-end of all 
duplex molecules provided by PCR. Sequencing of the HNL cDNA 
in the plasmid pCR II was performed according to the dideoxy termi- 
nation method [11]. 
2.5. Southern blot analysis 
HNL cDNA containing plasmids pCR II and pET 11 a were separatly 
digested with EcoRI, NdeI and BamHI followed by agarose gelelectro- 
phoresis, capillary transfer of restriction fragments on nylon membrane 
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and hybridization using standard methods [12]. 'HNL PAT': 5'-CAA- 
GAG CTACAATGTCACCTCCGTCCTG-3' was labelled with digo- 
xygenine (MWG-Biotech, Germany) and used as a probe in Southern 
blot hybridization. 
2.6. Bacterial expression 
For HNL expression the cDNA was selectively amplified with two 
oligonucleotide primers: 'HNLF' 5'-ATTCATATGCAGGACTCGA- 
CGTCGGAC-3' and 'HNLR' 5'-CAGGGATCC CTAGCCGTCGA- 
TGCATTGATCGA-3' using PCR II-HNL cDNA as template. 
'HNLF' incorporates sequences for a unique NdeI site and an initiating 
methionine. 'HNLR' introduces equences for a stop codon and a 
unique BamHI site. Ligation into the plasmid pET 1 la and expression 
in E. coli strain HMS 174 [DE3] followed as previously described [13]. 
2. 7. SDS-PA GE and Western blot analysis 
SDS-PAGE was performed by the method of Laemmli [14]. Western 
blots were performed as published by Bergmann et al. [15]. After blot- 
ting the proteins were further subjected to automated amino acid se- 
quence determination in a Knauer sequencer by the method escribed 
in [16]. 
3. Results and discussion 
Total HNL RNA was isolated from different ovarian cancer 
cell lines and bone marrow cells and used as templates for 
reverse transcription. Bone marrow cells were expected to be 
a good source for HNL mRNA as the protein was found to be 
expressed in human leukocytes [2]. Ovarian cancer cell cDNA 
seemed also to be a suitable source for HNL cDNA because 
the supernantant of these cells contain this protein (not pub- 
lished) as revealed by specific ELISA procedures [17]. 
Since only protein and no DNA information of HNL was 
available when we started these studies, the degeneracy of 
codons for amino acids had to be considered in the design of 
primers for the PCR technique. The use of selective oligonucle- 
otides had to represent the potential nucleic acid sequences for 
each alternate codon. Oligonucleotide design which take ac- 
count of this problems requires neutral bases like deoxyinosine 
[18]. Therefore HNL primers were designed by the DNA back- 
translate (Genetic Computer Group), containing five de- 
oxyinosines each, according to the mature HNL amino acid 
sequence [19]. Fig. 1A shows the products of the PCR amplifi- 
cation reactions obtained with these oligonucleotides at the 
optimized low annealing temperature of 50°C. Variation of the 
annealing temperature below 45°C or above 55°C resulted in 
unspecific amplification products or in no amplification reac- 
tion (not shown). The amplification product obtained by the 
use of cDNA from OC 1, OC 2, OC 6 or bone marrow cells 
had a lenght of 534 bp which was in accordance with the 
expected size of the DNA encoding the whole mature part of 
HNL. Possible prepro sequences of the HNL at the 5'- and 
3'-coding region could not be revealed by this approach but 
were not essential for cloning and expression of rHNL in E. coli 
[131. 
Sequence determinations of the 534 bp OC 1, OC 6 and bone 
marrow cDNAs were carried out in the pCR II vector. South- 
ern blot analyses were performed to obtain positive pCR II- 
HNL cDNA clones (Fig. 1B). This pCR II vector system takes 
advantage of the Y-deoxyadenylate extension which the Taq 
DNA polymerases added to the termini of amplified cDNA [20] 
and allows direct cloning of the PCR product in appropriate 
constructed vectors (TA cloning). HNL oligonucleotide design 
therefore needed no additional unique restriction sites which 
were candidates for unspecific template hybridization yielding 
in various PCR amplification products. 
The determined sequence data are shown in Fig. 2. The 
isolated 534 bp cDNA corresponded to the amino acid se- 
quence of the mature HNL protein [2]. The HNL cDNA se- 
quence using OC 6 transcripts as template is compared with the 
related lipocalin cDNA sequences of mouse (24p3) [4] and rat 
(~2microglobulin related protein) [3] indicating strong con- 
served nucleotide homologies with an overall conformity of 
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Fig. 1. (A) A 1% agarose gel electrophoresis of PCR products obtained by PCR reaction (see section 2) with inosine containing HNL primers and 
different emplates. Lane 1, pBR 322 fragments (DNA L~ingenstandard X, Boehringer Mannheim, Germany) as a molecular weight standard. 
Template cDNA from; lane 2, OVCAR 3; lane 3, OC 1; lane 4, OC 2; lane 5, OC 6 and lane 6, bone marrow cells. The DNA samples were visualized 
by ethidium bromide fluorescence. (B) Southern blot analysis of EcoRI digested pCR II containing HNL cDNA. Lane 1, molecular weight standard. 
HNL cDNA from; lane 2, OC 1; lane 4, OC 6; lane 6, bone marrow cells. Lane 3, 5, 7 plasmids before digestion as control. Sequence analysis of 
the 534 bp cDNA revealed identity with the DNA backtranslate (Genetics Computer Group) of the mature HNL protein. 
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HNL 
rat ctcttcctcc tccggcacac atcggaccta gtagctgctg aaaccatggg 50 
24p3 agaccta gtagctgtgg aaaccatggc 27 
HNL 
rat cctgggtgtc ctgtgtctgg cccttgtcct gcttggggtc ctgcagaggc i00 
24p3 cctgagtgtc atgtgtctgg gccttgccct gcttggggtc ctgcagagcc 77 
HNL cagga ctc~acHtc~ gacctgatcc cggccccacc tctgagcaag 45 
rat aggcccagga ctcaactcag aacttgatcc ctgccccacc tctgatcagt 150 
24p3 aggcccagga ctcaactcag aacttgatcc ctgccccatc tctgctcact 127 
HNL gtccctctgc agcagaactt ccaggacaac caattccagg ggaagtggta 95 
rat gtgcccctgc agccaggctt ctggaccgaa cggttccagg gcaggtggtt 200 
24p3 gtccccctgc agccagactt ccggagcgat cagttccggg gcaggtggta 177 
HNL tgtggtaggc ctggcaggga atgcaattct cagag.aaga caaagacccg 144 
rat cgttgtcggc ctggcagcga atgcggtcca gaaagaaaga caaag..ccg 248 
24p3 cgttgtgggc ctggcaggca atgcggtcca gaaaaaaaca gaagg..cag 225 
HNL c.aaaagatg tatgccacca tctatgagct gaaagaagac aagagctaca 193 
rat ctttaccatg tacagcacca tctatgagct acaggaagac aatagctaca 298 
24p3 ctttacgatg tacagcacca tctatgagct acaagagaac aatagctaca 275 
HNL atgtcacctc cgtcctgttt aggaaaaaga a ...... gtg tgactactgg 237 
rat acgtcacttc catcctcgtc ag ...... gg gccagggctg tcgctactgg 342 
24p3 atgtcacctc catcctggtc agggaccagg accagggctg tcgctactgg 325 
HNL atcaggactt ttgttccagg ttgccagccc ggcgagttca cgctgggcaa 287 
rat atcagaacat tcgttccaag ctccaggcct ggccagttca ccctggggaa 392 
24p3 atcagaacat ttgttccaag ctccagggct ggccagttca ctctgggaaa 375 
HNL cattaagagt taccctggat taacgagTta cctcgtccga gtggtgagca 337 
rat tattcacagc taccctcaga tacagagcta cgatgtgcaa gtggccgaca 442 
24p3 tatgcacagg tatcctcagg tacagagcta caatgtgcaa gtggccacca 425 
HNL ccaactacaa ccagcatgct atggtgttct tsaagaaagt ttctcaaaac 387 
rat ctgactacga ccagtttgcc atggtatttt tccagaagac ctctgaaaac 492 
24p3 cggactacaa ccagttcgcc atggtatttt tccgaaagac ttctgaaaac 475 
HNL agggagtact tcaagatcac ~ctctacggg agaaccaagg agctgacttc 437 
rat aaacagtact tcaaagtcac cctgtacgga agaaccaagg ggctgtccga 542 
24p3 aagcaatact tcaaaattac cctgtatgga agaaccaagg agctgtcccc 525 
HNL ggaactaaag gagaacttca tccgcttctc caaatctctg ggcctccctg 487 
rat tgaactgaag gagcgattcg tcagctttgc caagtctctg ggcctcaagg 592 
24p3 tgaactgaag gaacgtttca cccgctttgc caagtctctg ggcctcaagg 575 
HNL aaaaccacat cgtcttccc~ gtcccsatcg a~caAtgsat cgacggc 534 
rat ataacaacat cgttttctct gttcccaccg accaatgcat tgacaactga 642 
24p3 acgacaacat catcttctct gtccccaccg accaatgcat tgacaactga 625 
rat acagacggtg agcgtggctg actgggatgt gcagtggcct gatggttcag 692 
24p3 atgggtggtg agtgtggctg actgggatgc gcagagaccc aatggttcag 675 
rat gtcccacctg tctgtctgcc gctccatctt tcctgttgcc agagaatcac 742 
24p3 gcgctgcctg tctgtctgcc actccatctt tcctgttgcc agagagccac 725 
rat ctggctgccc caccagccat gattccatca agcatctgat ccc...tctt 789 
24p3 ctggctgccc caccagccac cataccaagg agcatctgga gcctcttctt 775 
rat atttgatcag ctctccccat ccacctgtgt taacgctgcc ccaccaacgg 839 
24p3 atttggccag cactccccat ccacctgtct taa ..... ca ccaccaa.tg 819 
rat gctccccctt tctgctgaat aaacacatgt ccccaaa 876 
24p3 gcgtcccctt tctgctgaat aaatacatgc cccc 853 
Fig. 2. cDNA sequence of the mature HNL protein compared with the cDNA sequences of mouse oncogene protein 24p3 and rat 0~ 2microglobulin- 
related protein. Two clones of HNL cDNA derived from OC 6 (shown) and bone marrow cells show differences in four base pairs (big letters, see 
text). Boldface letters indicate base pairs conserved among the three lipocalins. Underlined letters indicate different base pairs compared with the 
cDNA sequence described by Bundegaard et at. [21]. 
71% (HNL, mouse), 72% (HNL, rat) and 86% (rat, mouse). 
Alignment of  HNL-OC 6 cDNA with HNL-bone marrow 
cDNA shows base pair exchanges in four cases (Gg--,C; 
T315---~C; G4°8---~C; C5°7---~T) which, however, do not 
lead to an amino acid exchange. Bundgaard et al. [21] described 
a cDNA of HNL from a chronic myelogenous leukemia cDNA 
library which differs at 10 highly degenerated codon positions 
(see Fig. 2) resulting also in the same derived amino acid se- 
quence of rHNL protein. Further investigations are needed to 
show whether mutations of the cDNAs or/and the use of syn- 
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thesized primers for PCR [21] are responsible for the sequence 
differences found. 
Computer HNL cDNA alignment of the three lipocalin mo- 
tifs [25] with other lipocalin members (Fig. 3), like c~ mi- 
croglobulin [22], retinol binding protein [23] and ~ acid 
glycoprotein [24] showed high homologies of 50~68%. In con- 
trast to this there were only 30~0% homologies on the level of 
the amino acids. This underlined the conservation of these 
lipocalin motifs at the cDNA level and facilitates the screening 
for new members of the lipocalin family by PCR techniques 
using degenerated oligonucleotides designed according to the 
conserved sequence motifs. 
In order to produce high amounts of the HNL protein for 
the purpose of functional and structural studies we expressed 
the protein in E. coli. For this purpose the pET 11 vector system 
[26] which allows the expression of the mature amino acid 
sequence starting with an initiating methionine was chosen. 
HNL cDNA containing a unique Ndel, a unique BamHI site 
and a stop codon was selectively amplified with 'HNLR'  and 
'HNLF '  oligonucleotides u ing pCR I I -HNL plasmid as tem- 
plate. After restriction digestion the amplification product was 
ligated into the NdeI and BamHI sites of the T7 expression 
vector 1 la as previously described for TIMP-1 [13]. The plas- 
mid pET 1 la-HNL was transformed into E. coli strain HMS 
174 [DE3]. In this host vector system the expression of rHNL 
was very efficient and rHNL was stored intracellularly in inclu- 
sion bodies in a denatured, insoluble form (not shown). Fifteen 
minutes after induction of the gene expression SDS-PAGE 
I. mot i f  
HNL 61 aact tccaggacaaccaat tccaggggaagtggtatgtggtagqcctgqca  
N F Q D N Q F Q G K W Y V V G L A  
rat 61 ggct tc tggaccgaacggt tccagggcaggtggt tcgt tg tcggcctggca  
G F W T E R F Q G R W F V V G I ,  A 
a lmg 43 aact tcaatatc tc tcggatc ta tgggaagtggtacaacctggccatcmqt  
N F N I S R I Y G K W Y N L A I G  
RBP 40 aacttcgacaaggctcgcttctctgggacctggtacgccatggccaagaag 
N F D K A R F S G T W Y A M A K K  
a]ac43  aacgccaccctggaccagatcactggcaagtggttttatatcgcatcggcc 
N A T L D Q I T G K W F ' Y I A S A  
2. mot i f  
I INL 322 gtccgagtggtgagcaccaactacaaccagcatgctatggtg[ t c 
V R V V S T N Y N Q H A M V F 
rat 322 gt gcaagt  ggccgacactgact  acgaccagt  t t qccat  qgt at I ~ 
v Q v A l) T D Y [) Q ~ A M V F 
a lmg 301 t cct  at g tggt  ccacaccaact  a tgatgagt  at gccat  t t t cc~ g 
S Y V V H T N Y D E Y A ] F L 
RBP 310 cactggat  cgt cgacacagact  acgacacgt  at gccgt  acagt  ac 
H W I V D T [3 Y D T Y A V Q Y 
a]ac  292 tt cgct  cact  t gct ga t cct cagggacaccaagacct  aca t gct t 
F A H L L I L D, D T K T Y M l, 
3. mot i f  
HNL 409 ct ct acgggagaaccaaggagctgact  t cggaact  aaagqagaact  t c 
L Y G R T K E L T S E L K E N F 
rat 409 c tgt  acggaagaaccaaggggct  gt ccgat  gaact  gaaggagcqat  t c 
L Y G R T K G L S D E L K E R F 
a lmg 391 c tc tacgggcgggcgccgcagct  gagggaaact  ct cot qcaggact  t c 
L Y G R A P Q L R E T L L Q D F 
RBP 406 gtgt t  t t cccgggaccccaacggcctgcccccagaaqcgcagaagat  t 
V F S R D P N G L P P E A Q K I 
a lac  376 gt ct atgct  gacaagccagagacgaccaaggagcaactgggaqaqt  t c 
v Y A D K P E T T ~ ~ Q L c E v 
Fig. 3. Comparison of three conserved sequence motifs of some 
lipocalin family members [25]. DNA sequence numbers are related to 
the amino acid sequence of the mature proteins. Sequences were com- 
pared by the wordsearch program (Genetics Computer Group). Bold- 
face letters indicate the only invariant residue throughout the lipocalin 
superfamily tryptophan [7]. Footnotes: rat, rat c% microglobulin-related 
protein; almg, human ~ microglobulin [22]; RBR human retinol bind- 
ing protein [23]; alac, human ~ acid glycoprotein [24]. 
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Fig. 4. Western blot analysis of E. coli cell pellet 4h after induction of 
rHNL gene expression with specific anti-HNL IgG [17] after SDS 
gelelectrophoresis: lane 1, molecular weight markers (Pharmacia, 
Freiburg, Germany); lane 2, rHNL (OC 6); lane 3, rHNL (bone 
marrow). 
analysis indicated a production of an additional protein band 
of 21 kDa, the molecular weight of which was in accord with 
the calculated molecular mass of the HNL protein. Four hours 
after induction, the amount of the expression product was in- 
creased to about 15% of total bacterial protein. Western blot 
analysis of the E. coli cell pellet with rabbit polyclonal anti- 
HNL antibodies [17] showed cross reactivity with the recombi- 
nant 21 kDa protein indicating the production of rHNL (Fig. 
4). The N-terminus was determined to be QDSTSDLIPAPP 
which was identical to the one of the mature HNL. The starting 
methionine was processed by E. coli [27]. 
In this paper we demonstrated for the first time that ovarian 
cancer cells produce HNL mRNA. As neutrophils during leu- 
kodiapedesis, cancer cells have to penetrate through the base- 
ment membrane when they become invasive. Further investiga- 
tions have to show whether the lipocalin contributes to this 
process. 
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